LifeSci Capital Initiates Coverage On Celcuity with Outperform Rating, Announces Price Target of $27
Portfolio Pulse from Benzinga Newsdesk
LifeSci Capital has initiated coverage on Celcuity (NASDAQ:CELC) with an Outperform rating and set a price target of $27.

August 26, 2024 | 2:46 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
LifeSci Capital has initiated coverage on Celcuity with an Outperform rating and a price target of $27, indicating a positive outlook for the stock.
The initiation of coverage with an Outperform rating and a specific price target of $27 suggests that the analyst expects the stock to perform well. This is likely to positively influence investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100